ESSI — what changed in the latest 10-Q
A section-by-section comparison of ESSI's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-09-14 vs the prior 10-Q · 2026-06-23
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +6 | −1 | ~11 | 21 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 1 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 18 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Other information
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-09-14
The Company commenced limited revenue-generating operations through its Herbo Pay platform during the three months ended April 30, 2026. During the three and six months ended July 31, 2026, the Company recorded net revenue of $1,952 and $2,205, respectively (three and six months ended July 31, 2025 …
The net loss for the three months ended July 31, 2026 was $256,314, compared to a net loss of $262,843 for the three months ended July 31, 2025, a decrease of $6,529. The decrease reflects the $9,445 reduction in other expenses and the $1,952 of revenue recognized in the current quarter, partially o…
During the six months ended July 31, 2026, the Company generated net revenue of $2,205, compared to $nil during the six months ended July 31, 2025. The Company commenced limited revenue-generating operations through its Herbo Pay platform during the three months ended April 30, 2026, and revenue for…
During the six months ended July 31, 2026 and 2025, the Company incurred total operating expenses of $480,248 and $497,193, respectively, a decrease of $16,945. Management and consulting fees were $245,000 (2026) and $251,000 (2025). Research, development, and promotion expense decreased to $140,738…
The Company recorded total other expenses of $21,048 during the six months ended July 31, 2026, consisting entirely of interest expense, compared to $39,071 during the six months ended July 31, 2025, which comprised interest expense of $19,295 and interest expense on related party obligations of $19…
Text removed vs the prior filing · source: 10-Q · 2026-06-23
During the three months ended April 30, 2026, the Company commenced limited revenue-generating operations through its Herbo Pay platform and recorded net revenue of $253. The Company remains in an early commercialization stage and continues to seek additional users of its software platforms.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice